Skip to main content
SpringerLink
Log in

Comparison of the antihypertensive effect of propranolol and practolol combined with chlorthalidone

  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

A double blind cross-over trial of fixed doses of propranolol (640 mg/day) and the cardioselective drug practolol (1600 mg/day) was performed in 28 patients with essential hypertension whose blood pressure was not adequately controlled by chlorthalidone (100 mg 3 times weekly) alone. Chlorthalidone alone was given during the first (control) period, and it was continued throughout the propranolol and practolol treatment periods, each of 10 weeks. The systolic and diastolic blood pressures were lowered significantly by both the beta blocking drugs. The changes in blood pressure caused by altering the patient's position were the same after both beta blockers. Propranolol produced slightly lower values than practolol, but the difference was significant only for diastolic blood pressure in the sitting and supine positions. In individual patients the final blood pressure after propranolol was correlated with the final blood pressure after practolol. Only minimal side-effects of either drug were noticed. It is concluded that the doses employed both of propranolol and practolol had a good and approximately equal antihypertensive effect when combined with chlorthalidone treatment. There was no correlation between the final blood pressure and plasma renin activity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Prichard, B.N.C., Gillam, P.M.S.: Treatment of hypertension with propranolol. Brit. med. J.1969 I, 7–16

    Google Scholar 

  2. Zacharias, F.J., Cowen, K.J.: Controlled trial of propranolol in hypertension. Brit. med. J.1970 I, 471–474

    Google Scholar 

  3. Tarazi, R.C., Dustan, H.P.: Beta adrenergic blockade in hypertension. Amer. J. Cardiol.29, 633–640 (1972)

    Google Scholar 

  4. Castenfors, J., Johnsson, H., Orö, L.: Effect of alprenolol on blood pressure and plasma renin activity in hypertensive patients. Acta med. scand.193, 189–195 (1973)

    Google Scholar 

  5. Hochberg, H.M., Salomon, H.: Accuracy of an automated ultrasound blood pressure monitor. Curr. ther. Res.13, 129–138 (1971)

    Google Scholar 

  6. Fröhlich, E.D., Kozul, V.J., Tarazi, R.C., Dustan, H.P.: Physiological comparison of labile and essential hypertension. Circulat. Res.28 (Suppl. 1) 55–63 (1970)

    Google Scholar 

  7. Bello, C.J., Sevy, R.W., Harakal, C., Hillyer, P.N.: Relationship between clinical severity of disease and haemodynamic patterns in essential hypertension. Amer. J. med. Sci.253, 194–208 (1967)

    Google Scholar 

  8. Molzahn, M., Dissmann, Th., Gotzen, R., Lohmann, F.W.: Der Einfluss einer akuten und chronischen Verminderung des Herzzeitvolumens auf den arteriellen Blutdruck bei beginnender Hypertonie. Klin. Wschr.49, 476–484 (1971)

    Google Scholar 

  9. Bodem, G., Brammell, H.L., Weil, J.V., Chidsey, Ch. A.: Pharmacodynamic studies of beta adrenergic antagonism included in man by propranolol and practolol. J. clin. Invest.52, 747–754 (1973)

    Google Scholar 

  10. Alexander, J.M., Menard, J., Chevillard, C., Schmitt, H.: Increased plasma renin activity induced in rats by physostigmine and effects of alpha and beta receptors blocking drugs thereon. Europ. J. Pharmacol.12, 127–131 (1970)

    Google Scholar 

  11. Bühler, F.R., Laragh, J.H., Baer, L., Vaughan, E.D. Jr., Brunner, H.R.: Propranolol inhibition of renin secretion. New Engl. J. Med.287, 1209 (1972)

    Google Scholar 

  12. Hansson, L.: Beta adrenergic blockade in essential hypertension. Acta med. Scand. Suppl.550, 7–40 (1973)

    Google Scholar 

  13. Berglund, G., Hansson, L.: A within-patient comparison of alprenolol and propranolol in hypertension. Acta med. Scand.193, 547–550 (1973)

    Google Scholar 

  14. Felix, R.H., Ive, F.A., Dahl, M.G.C.: Cutaneous and ocular reactions to practolol. Brit. med. J.1974 IV, 321–324

    Google Scholar 

  15. Brown, P., Baddeley, H., Read, A.E., Davies, J.D., Mc Garry, J.: Sclerosing peritonitis, an unusual reaction to a beta-adrenergic blocking drug (practolol). Lancet1974 II, 1477–1481

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Nephrology and Hypertension, University Hospital, Utrecht, The Netherlands

    G. G. Geyskes, A. Stutterheim, P. Boer & E. J. Dorhout Mees

Authors
  1. G. G. Geyskes
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Stutterheim
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. P. Boer
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. E. J. Dorhout Mees
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Geyskes, G.G., Stutterheim, A., Boer, P. et al. Comparison of the antihypertensive effect of propranolol and practolol combined with chlorthalidone. Eur J Clin Pharmacol 9, 85–90 (1975). https://doi.org/10.1007/BF00614001

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00614001

Key words

Search

Navigation